REGN10933+REGN10987

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN10933+REGN10987, covering 2022-04-08 to 2022-04-08. Get the full timeline:

Most recent: Clinical Trial Update: COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection [Phase 2]

See pricing